← FDA Drug Approvals (Drugs@FDA)

APIXABAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2020-09-11

Drug application

FDA Application #

ANDA209898

Application type

Abbreviated New Drug Application (Generic)

Brand name

APIXABAN

Generic name

APIXABAN

Active ingredients

APIXABAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

REGCON HOLDINGS

Manufacturer

Indoco Remedies Limited

First approval

2020-09-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown